ES2679282T3 - Porcinos transgénicos que carecen de cadena ligera de inmunoglobulina endógena - Google Patents

Porcinos transgénicos que carecen de cadena ligera de inmunoglobulina endógena Download PDF

Info

Publication number
ES2679282T3
ES2679282T3 ES12161321.0T ES12161321T ES2679282T3 ES 2679282 T3 ES2679282 T3 ES 2679282T3 ES 12161321 T ES12161321 T ES 12161321T ES 2679282 T3 ES2679282 T3 ES 2679282T3
Authority
ES
Spain
Prior art keywords
immunoglobulin
gene
porcine
locus
light chain
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES12161321.0T
Other languages
English (en)
Spanish (es)
Inventor
Kevin Wells
David Ayares
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Revivicor Inc
Original Assignee
Revivicor Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Revivicor Inc filed Critical Revivicor Inc
Application granted granted Critical
Publication of ES2679282T3 publication Critical patent/ES2679282T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0276—Knock-out vertebrates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/8509—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells for producing genetically modified animals, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/873—Techniques for producing new embryos, e.g. nuclear transfer, manipulation of totipotent cells or production of chimeric embryos
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/075—Animals genetically altered by homologous recombination inducing loss of function, i.e. knock out
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/101—Bovine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/102—Caprine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/103—Ovine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/108—Swine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/01—Animal expressing industrially exogenous proteins
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A01K2267/025—Animal producing cells or organs for transplantation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/20—Pseudochromosomes, minichrosomosomes
    • C12N2800/204—Pseudochromosomes, minichrosomosomes of bacterial origin, e.g. BAC
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/20—Pseudochromosomes, minichrosomosomes
    • C12N2800/206—Pseudochromosomes, minichrosomosomes of yeast origin, e.g. YAC, 2u
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2800/00—Nucleic acids vectors
    • C12N2800/30—Vector systems comprising sequences for excision in presence of a recombinase, e.g. loxP or FRT
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Plant Pathology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Veterinary Medicine (AREA)
  • Animal Husbandry (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ES12161321.0T 2004-10-22 2005-10-24 Porcinos transgénicos que carecen de cadena ligera de inmunoglobulina endógena Expired - Lifetime ES2679282T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US62143304P 2004-10-22 2004-10-22
US621433P 2004-10-22

Publications (1)

Publication Number Publication Date
ES2679282T3 true ES2679282T3 (es) 2018-08-23

Family

ID=36228428

Family Applications (1)

Application Number Title Priority Date Filing Date
ES12161321.0T Expired - Lifetime ES2679282T3 (es) 2004-10-22 2005-10-24 Porcinos transgénicos que carecen de cadena ligera de inmunoglobulina endógena

Country Status (10)

Country Link
US (1) US20060130157A1 (enExample)
EP (2) EP1811832A4 (enExample)
JP (5) JP2008517608A (enExample)
KR (1) KR20070072608A (enExample)
CN (1) CN101389214A (enExample)
AU (1) AU2005299413A1 (enExample)
CA (3) CA2585098C (enExample)
ES (1) ES2679282T3 (enExample)
NZ (1) NZ554824A (enExample)
WO (1) WO2006047603A2 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7074983B2 (en) * 1999-11-19 2006-07-11 Kirin Beer Kabushiki Kaisha Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
AU1777301A (en) * 1999-11-19 2001-05-30 Hematech, Llc Production of ungulates, preferably bovines that produce human immunoglobulins
US7414170B2 (en) * 1999-11-19 2008-08-19 Kirin Beer Kabushiki Kaisha Transgenic bovines capable of human antibody production
AU2003290689A1 (en) * 2002-11-08 2004-06-03 Kyowa Hakko Kirin Co., Ltd. Transgenic ungulates having reduced prion protein activity and uses thereof
CA2563064A1 (en) 2004-04-22 2005-11-10 Kirin Beer Kabushiki Kaisha Transgenic animals and uses thereof
US20080026457A1 (en) * 2004-10-22 2008-01-31 Kevin Wells Ungulates with genetically modified immune systems
CA2617930A1 (en) 2005-08-09 2007-03-29 Revivicor, Inc. Transgenic ungulates expressing ctla4-ig and uses thereof
EP2602323B1 (en) * 2007-06-01 2018-02-28 Open Monoclonal Technology, Inc. Compositions and methods for inhibiting endogenous immunoglobin genes and producing transgenic human idiotype antibodies
JP5511144B2 (ja) * 2008-02-12 2014-06-04 学校法人福岡大学 てんかんモデル非ヒト哺乳動物
DK2348827T3 (en) 2008-10-27 2015-07-20 Revivicor Inc IMMUNICIPLY COMPROMATED PETS
US9420770B2 (en) 2009-12-01 2016-08-23 Indiana University Research & Technology Corporation Methods of modulating thrombocytopenia and modified transgenic pigs
US10920242B2 (en) 2011-02-25 2021-02-16 Recombinetics, Inc. Non-meiotic allele introgression
EP3450563A1 (en) * 2011-02-25 2019-03-06 Recombinetics, Inc. Genetically modified animals and methods for making the same
PT2931030T (pt) * 2012-12-14 2020-08-03 Open Monoclonal Tech Inc Polinucleótidos que codificam anticorpos de roedores com idiótipos humanos e animais que os compreendem
MX2016014066A (es) * 2014-04-28 2017-05-03 Recombinetics Inc Edicion de genes multiples en cerdos.
US11725044B2 (en) * 2014-10-15 2023-08-15 Xenothera Method for producing polyclonal antibodies with improved complement-dependent cytotoxicity
EP4056031A1 (en) * 2016-08-11 2022-09-14 The Jackson Laboratory Methods and compositions relating to improved human red blood cell survival in genetically modified immunodeficient non-human animals
CN109906272A (zh) * 2016-10-31 2019-06-18 国立大学法人鸟取大学 产生人抗体的非人动物和使用该非人动物的人抗体制作方法
US10883084B2 (en) 2018-10-05 2021-01-05 Xenotherapeutics, Inc. Personalized cells, tissues, and organs for transplantation from a humanized, bespoke, designated-pathogen free, (non-human) donor and methods and products relating to same
US10799614B2 (en) 2018-10-05 2020-10-13 Xenotherapeutics, Inc. Xenotransplantation products and methods
CN112961863B (zh) * 2019-06-04 2023-03-10 中国农业科学院兰州兽医研究所 猪IgA类别转换后转录本α长、短序列
CN111154889B (zh) * 2020-01-16 2021-08-03 广西扬翔股份有限公司 一种与猪体重相关的snp分子标记及其应用和获取方法
CN115918611B (zh) * 2021-10-25 2025-06-27 百奥赛图(北京)医药科技股份有限公司 Tgfbr2基因人源化非人动物及其构建方法和应用
CN116076438B (zh) * 2023-03-21 2024-01-30 湖南中医药大学 类风湿关节炎合并间质性肺病动物模型及其构建方法和应用
CN119785879B (zh) * 2024-11-27 2025-11-14 兰州大学 基于多组学策略锁定与绵羊尾脂重相关分子标记的方法及应用

Family Cites Families (215)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US615374A (en) 1898-12-06 Ditch in g atxac h m e nt fo r p lows
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US4994384A (en) 1986-12-31 1991-02-19 W. R. Grace & Co.-Conn. Multiplying bovine embryos
US4889806A (en) 1987-04-15 1989-12-26 Washington University Large DNA cloning system based on yeast artificial chromosomes
US5057420A (en) 1987-06-05 1991-10-15 Granada Biosciences, Inc. Bovine nuclear transplantation
HUT55052A (en) 1988-03-24 1991-04-29 Gen Hospital Corp Process for producing artificial chromosome vector
US5270201A (en) 1988-03-24 1993-12-14 The General Hospital Corporation Artificial chromosome vector
EP0435928A1 (en) 1988-09-21 1991-07-10 Animal Biotechnology Cambridge Limited Derivation of pluripotential embryonic cell lines from domestic animals
GB8823068D0 (en) 1988-09-30 1988-11-09 Ici Plc Recombinant dna
GB8823869D0 (en) 1988-10-12 1988-11-16 Medical Res Council Production of antibodies
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
US4944384A (en) 1989-01-30 1990-07-31 Hay & Forage Industries Trash discharge apparatus for crop transferring conveyor mechanism
US4997384A (en) 1989-04-17 1991-03-05 Otis Engineering Corporation Wet connector
GB8920211D0 (en) 1989-09-07 1989-10-18 Ici Plc Diagnostic method
WO1991006667A1 (en) 1989-11-06 1991-05-16 Cell Genesys, Inc. Production of proteins using homologous recombination
DE69133566T2 (de) 1990-01-12 2007-12-06 Amgen Fremont Inc. Bildung von xenogenen Antikörpern
CA2086092A1 (en) 1990-07-13 1992-01-14 Douglas A. Treco Library screening method
US5770429A (en) 1990-08-29 1998-06-23 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
KR100272077B1 (ko) * 1990-08-29 2000-11-15 젠팜인터내셔날,인코포레이티드 이종 항체를 생산할 수 있는 전이유전자를 가진 인간이외의 동물
US5545806A (en) 1990-08-29 1996-08-13 Genpharm International, Inc. Ransgenic non-human animals for producing heterologous antibodies
US5625126A (en) * 1990-08-29 1997-04-29 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US6300129B1 (en) 1990-08-29 2001-10-09 Genpharm International Transgenic non-human animals for producing heterologous antibodies
JPH06506105A (ja) 1990-08-29 1994-07-14 ファーミング　ビーブイ 哺乳動物細胞における相同性組換え
US5661016A (en) * 1990-08-29 1997-08-26 Genpharm International Inc. Transgenic non-human animals capable of producing heterologous antibodies of various isotypes
US5814318A (en) 1990-08-29 1998-09-29 Genpharm International Inc. Transgenic non-human animals for producing heterologous antibodies
US5789650A (en) 1990-08-29 1998-08-04 Genpharm International, Inc. Transgenic non-human animals for producing heterologous antibodies
US5633425A (en) 1990-08-29 1997-05-27 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US5382524A (en) 1990-10-24 1995-01-17 The Mount Sinai School Of Medicine Of The City University Of New York Cloning and expression of biologically active α-n-acetylgalactosaminidase
ATE204328T1 (de) 1991-03-11 2001-09-15 Syngenta Ltd Biozide proteine
WO1992022670A1 (en) 1991-06-12 1992-12-23 Genpharm International, Inc. Early detection of transgenic embryos
WO1992022645A1 (en) 1991-06-14 1992-12-23 Genpharm International, Inc. Transgenic immunodeficient non-human animals
WO1993004169A1 (en) * 1991-08-20 1993-03-04 Genpharm International, Inc. Gene targeting in animal cells using isogenic dna constructs
US5288625A (en) 1991-09-13 1994-02-22 Biologic Research Center Of The Hungarian Academy Of Sciences Mammalian artificial chromosomes
WO1993008270A1 (en) 1991-10-15 1993-04-29 Agracetus, Inc. Particle-mediated transformation of mammalian unattached cells
CA2124967C (en) 1991-12-17 2008-04-08 Nils Lonberg Transgenic non-human animals capable of producing heterologous antibodies
JPH07508410A (ja) 1992-06-18 1995-09-21 ジェンファーム　インターナショナル　インコーポレイテッド 酵母人工染色体を有するトランスジェニック非ヒト動物の製造方法
WO1994002602A1 (en) 1992-07-24 1994-02-03 Cell Genesys, Inc. Generation of xenogeneic antibodies
US5981175A (en) 1993-01-07 1999-11-09 Genpharm Internation, Inc. Methods for producing recombinant mammalian cells harboring a yeast artificial chromosome
US5496720A (en) 1993-02-10 1996-03-05 Susko-Parrish; Joan L. Parthenogenic oocyte activation
WO1994023049A2 (en) 1993-04-02 1994-10-13 The Johns Hopkins University The introduction and expression of large genomic sequences in transgenic animals
GB9308271D0 (en) 1993-04-21 1993-06-02 Univ Edinburgh Method of isolating and/or enriching and/or selectively propagating pluripotential animal cells and animals for use in said method
AU6819494A (en) 1993-04-26 1994-11-21 Genpharm International, Inc. Transgenic non-human animals capable of producing heterologous antibodies
US6096878A (en) 1993-05-10 2000-08-01 Japan Tobacco Inc. Human immunoglobulin VH gene segments and DNA fragments containing the same
US5523226A (en) 1993-05-14 1996-06-04 Biotechnology Research And Development Corp. Transgenic swine compositions and methods
US5851760A (en) 1993-06-15 1998-12-22 The Salk Institute For Biological Studies Method for generation of sequence sampled maps of complex genomes
WO1995003400A1 (en) 1993-07-23 1995-02-02 Johns Hopkins University School Of Medicine Recombinationally targeted cloning in yeast artificial chromosomes
JPH09502965A (ja) 1993-08-20 1997-03-25 ユニバーシティー オブ メディスン アンド デンティストリー オブ ニュー ジャージー インターフェロンガンマの副因子機能およびその受容体
US5597694A (en) 1993-10-07 1997-01-28 Massachusetts Institute Of Technology Interspersed repetitive element-bubble amplification of nucleic acids
US5625825A (en) 1993-10-21 1997-04-29 Lsi Logic Corporation Random number generating apparatus for an interface unit of a carrier sense with multiple access and collision detect (CSMA/CD) ethernet data network
JPH09509046A (ja) 1993-11-29 1997-09-16 ユニヴァーシティ オブ サウス フロリダ トランスジェニックマウス
WO1996001276A1 (en) 1994-07-06 1996-01-18 University Of Medicine & Dentistry Of New Jersey Expression of a functional human type i interferon receptor
US5643763A (en) 1994-11-04 1997-07-01 Genpharm International, Inc. Method for making recombinant yeast artificial chromosomes by minimizing diploid doubling during mating
US5733744A (en) 1995-01-13 1998-03-31 Cornell Research Foundation, Inc. Binary BAC vector
EP0823941A4 (en) 1995-04-28 2001-09-19 Abgenix Inc HUMAN ANTIBODIES DERIVED FROM IMMUNIZED XENO MOUSES
US6682729B1 (en) 1995-05-03 2004-01-27 University Of Maryland, Baltimore Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same
US5877159A (en) 1995-05-03 1999-03-02 University Of Maryland At Baltimore Method for introducing and expressing genes in animal cells and live invasive bacterial vectors for use in the same
US6150170A (en) 1998-05-03 2000-11-21 University Of Maryland At Baltimore Method for introducing and expressing genes in animal cells, and live invasive bacterial vectors for use in the same
US5985846A (en) 1995-06-07 1999-11-16 Baylor College Of Medicine Gene therapy for muscular dystrophy
US6348353B1 (en) 1995-06-07 2002-02-19 Case Western Reserve University Artificial mammalian chromosome
US6455254B1 (en) 1995-07-18 2002-09-24 Diversa Corporation Sequence based screening
JP2000513923A (ja) 1995-07-18 2000-10-24 ワシントン・ユニバーシティ 変異ｓ１８２遺伝子
WO1997004111A1 (en) 1995-07-21 1997-02-06 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services RecA-ASSISTED CLONING OF DNA
CA2230759C (en) 1995-08-29 2012-02-21 Kirin Beer Kabushiki Kaisha Chimeric animal and method for producing the same
US6166288A (en) 1995-09-27 2000-12-26 Nextran Inc. Method of producing transgenic animals for xenotransplantation expressing both an enzyme masking or reducing the level of the gal epitope and a complement inhibitor
US6133503A (en) 1995-10-31 2000-10-17 The Regents Of The University Of California Mammalian artificial chromosomes and methods of using same
WO1997016533A1 (en) 1995-10-31 1997-05-09 The Regents Of The University Of California Mammalian artificial chromosomes and methods of using same
US6150160A (en) 1995-11-16 2000-11-21 The John Hopkins University Compositions and methods of use of mammalian retrotransposons
US5997881A (en) 1995-11-22 1999-12-07 University Of Maryland, Baltimore Method of making non-pyrogenic lipopolysaccharide or A
US5866404A (en) 1995-12-06 1999-02-02 Yale University Yeast-bacteria shuttle vector
US5830696A (en) 1996-12-05 1998-11-03 Diversa Corporation Directed evolution of thermophilic enzymes
US20020132295A1 (en) 1996-02-09 2002-09-19 Short Jay M. Enzymes having transaminase and aminotransferase activity and methods of use thereof
US7288400B2 (en) 1996-02-16 2007-10-30 Verenium Corporation Nucleic acids encoding esterases and methods of making and using them
US6987016B2 (en) 1996-03-08 2006-01-17 Diversa Corporation α-galactosidases and methods for making and using them
WO1997037020A1 (en) 1996-04-01 1997-10-09 Genentech, Inc. Apo-2li and apo-3 apoptosis polypeptides
US6025155A (en) 1996-04-10 2000-02-15 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6077697A (en) 1996-04-10 2000-06-20 Chromos Molecular Systems, Inc. Artificial chromosomes, uses thereof and methods for preparing artificial chromosomes
US6495318B2 (en) 1996-06-17 2002-12-17 Vectorobjects, Llc Method and kits for preparing multicomponent nucleic acid constructs
US20020137185A1 (en) 1996-06-17 2002-09-26 Jay Short Enzymes having amidase activity and methods of use thereof
DE69719409T2 (de) 1996-06-18 2004-01-15 Rikagaku Kenkyusho Verfahren zur Reinigung von DNS
US20020102680A1 (en) 1996-07-03 2002-08-01 Robertson Dan E. Catalases
JP2000515011A (ja) 1996-07-09 2000-11-14 アメリカ合衆国 形質転換関連組換えクローニング
CN1230989A (zh) 1996-08-19 1999-10-06 马萨诸塞大学 通过种间核移植制备胚胎细胞或干细胞样细胞系
US6017755A (en) 1996-08-22 2000-01-25 Hsc Research & Development Limited MADR2 tumour suppressor gene
EP2060633A1 (en) 1996-08-26 2009-05-20 Chromo Research, Inc. Mammalian artificial chromosomes
US6187533B1 (en) 1996-09-10 2001-02-13 Arch Development Corporation Mutations in the diabetes susceptibility genes hepatocyte nuclear factor (HNF) 1 alpha (α), HNF1β and HNF4α
US6294712B1 (en) 1996-09-18 2001-09-25 Christian Jung Nematode-resistant gene
WO1998012336A1 (en) 1996-09-18 1998-03-26 Dnavec Research Inc. Artificial chromosome
US6462176B1 (en) 1996-09-23 2002-10-08 Genentech, Inc. Apo-3 polypeptide
US6020142A (en) 1996-10-04 2000-02-01 Millennium Pharmaceuticals, Inc. Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders
US6136566A (en) 1996-10-04 2000-10-24 Lexicon Graphics Incorporated Indexed library of cells containing genomic modifications and methods of making and utilizing the same
US6287854B1 (en) 1996-10-22 2001-09-11 Imperial Cancer Research Technology Limited Diagnosis of susceptibility to cancer and treatment thereof
DE69738539T2 (de) 1996-12-03 2009-03-26 Amgen Fremont Inc. Vollkommen humane Antikörper die EGFR binden
US7279316B2 (en) 1996-12-06 2007-10-09 Verenium Corporation Enzymes having glycosidase activity and methods of use thereof
US6358523B1 (en) 1996-12-06 2002-03-19 The Regents Of The University Of California Macromolecule-lipid complexes and methods for making and regulating
CA2274306A1 (en) 1996-12-16 1998-06-25 Mcgill University Human and mammalian dna replication origin consensus sequences
GB9702802D0 (en) 1997-02-12 1997-04-02 Babraham The Inst Yeast artificial chromosomes
WO1998040510A1 (en) 1997-03-11 1998-09-17 Regents Of The University Of Minnesota Dna-based transposon system for the introduction of nucleic acid into dna of a cell
JP3151657B2 (ja) 1997-03-26 2001-04-03 農林水産省農業生物資源研究所長 遺伝子導入法
ES2513043T3 (es) 1997-03-26 2014-10-24 Imperial Innovations Limited Proteína de fusión anticoagulante anclada a membrana de la célula
US5843671A (en) 1997-04-01 1998-12-01 Princeton University Methods for measuring trinucleotide repeat expansion in Saccharomyces cerevisiae
AU741630B2 (en) 1997-05-07 2001-12-06 Genomics One Corporation Improved cloning vector containing marker inactivation system
EP0996719A4 (en) 1997-05-13 2002-05-08 Amrad Operations Pty Ltd A novel nucleic acid molecule
US5972649A (en) 1997-05-29 1999-10-26 Incyte Pharmaceuticals, Inc. Polynucleotide sequence encoding human multiple endocrine neoplasia type 1 protein
US6156953A (en) 1997-06-03 2000-12-05 University Of Chicago Plant artificial chromosome compositions and methods
US6156574A (en) 1997-06-23 2000-12-05 The Rockefeller University Methods of performing gene trapping in bacterial and bacteriophage-derived artificial chromosomes and use thereof
US6143566A (en) 1997-06-23 2000-11-07 The Rockfeller University Methods of performing homologous recombination based modification of nucleic acids in recombination deficient cells and use of the modified nucleic acid products thereof
US6136952A (en) 1997-06-25 2000-10-24 University Of Washington Human jagged polypeptide, encoding nucleic acids and methods of use
US6207648B1 (en) 1997-07-24 2001-03-27 Trustees Of Boston University Methods of using cytochrome P450 reductase for the enhancement of P450-based anti-cancer gene therapy
US7056703B2 (en) 1997-08-06 2006-06-06 Diversa Corporation Polypeptides having polymerase activity and methods of use thereof
US6855365B2 (en) 1997-08-13 2005-02-15 Diversa Corporation Recombinant bacterial phytases and uses thereof
US6090584A (en) 1997-08-21 2000-07-18 University Technologies International Inc. Baculovirus artificial chromosomes and methods of use
IL135242A0 (en) 1997-09-26 2001-05-20 Athersys Inc Expression of endogenous genes by non-homologous recombination of a vector construct with cellular dna
US5874259A (en) 1997-11-21 1999-02-23 Wisconsin Alumni Research Foundation Conditionally amplifiable BAC vector
US6485910B1 (en) 1998-02-09 2002-11-26 Incyte Genomics, Inc. Ras association domain containing protein
US6277621B1 (en) 1998-02-26 2001-08-21 Medigene, Inc. Artificial chromosome constructs containing foreign nucleic acid sequences
US6080576A (en) 1998-03-27 2000-06-27 Lexicon Genetics Incorporated Vectors for gene trapping and gene activation
GB9807520D0 (en) 1998-04-09 1998-06-10 Univ Wales Medicine Modified biological material
US5981225A (en) 1998-04-16 1999-11-09 Baylor College Of Medicine Gene transfer vector, recombinant adenovirus particles containing the same, method for producing the same and method of use of the same
US6183957B1 (en) 1998-04-16 2001-02-06 Institut Pasteur Method for isolating a polynucleotide of interest from the genome of a mycobacterium using a BAC-based DNA library application to the detection of mycobacteria
GB9809280D0 (en) 1998-04-30 1998-07-01 Rpms Technology Ltd Immunosupression
CA2340622A1 (en) 1998-05-06 1999-11-11 Genprofile Ag Method for non-radioactive detection of membrane-bonded nucleic acids and test kit
US6723564B2 (en) 1998-05-07 2004-04-20 Sequenom, Inc. IR MALDI mass spectrometry of nucleic acids using liquid matrices
US6004804A (en) 1998-05-12 1999-12-21 Kimeragen, Inc. Non-chimeric mutational vectors
US6534262B1 (en) 1998-05-14 2003-03-18 Whitehead Institute For Biomedical Research Solid phase technique for selectively isolating nucleic acids
AUPP388298A0 (en) 1998-06-03 1998-06-25 Polychip Pharmaceuticals Pty Ltd Precursers of pharmaceutical compounds
US6413776B1 (en) 1998-06-12 2002-07-02 Galapagos Geonomics N.V. High throughput screening of gene function using adenoviral libraries for functional genomics applications
WO2000000609A2 (en) 1998-06-29 2000-01-06 Incyte Pharmaceuticals, Inc. Molecules associated with apoptosis
US6689606B2 (en) 1998-07-21 2004-02-10 M.L. Laboratories Plc Polynucleotide
AU5217599A (en) 1998-07-27 2000-02-21 Genotypes, Inc. Automatic eukaryotic artificial chromosome vector
BR9913643A (pt) 1998-08-11 2001-09-25 Univ Hawaii Transgênese de mamìferos através de injeção intracitoplásmica de espermatozóides
US6673909B1 (en) 1998-08-25 2004-01-06 The General Hospital Corporation Oligonucleotides for dysferlin, a gene mutated in distal myopathy and limb girdle muscular dystrophy
GB9821193D0 (en) 1998-09-30 1998-11-25 Medical Res Council Mammalian artificial chromosomes and uses thereof
US6632934B1 (en) 1998-09-30 2003-10-14 Board Of Regents, The University Of Texas System MORC gene compositions and methods of use
US6743906B1 (en) 1998-10-02 2004-06-01 Board Of Regents, The University Of Texas PPP2R1B is a tumor suppressor
GB9825555D0 (en) 1998-11-20 1999-01-13 Imp College Innovations Ltd Suppression of xenotransplant rejection
WO2000034497A2 (en) 1998-12-09 2000-06-15 The General Hospital Corporation Enhanced packaging of herpes virus amplicons and generation of recombinant virus vectors
EP1144631A3 (en) 1999-01-07 2002-01-30 Incyte Pharmaceuticals, Inc. Insulin-synthesis genes
US20020015950A1 (en) 1999-07-07 2002-02-07 Karen Anne Jones Atherosclerosis-associated genes
AU780754B2 (en) 1999-03-04 2005-04-14 Revivicor Inc Genetic modification of somatic cells and uses thereof
GB9909446D0 (en) 1999-04-23 1999-06-23 Medical Res Council Vector
US6544768B1 (en) 1999-05-11 2003-04-08 Cornell Research Foundation, Inc. Mammalian soluble adenylyl cyclase
US6284882B1 (en) 1999-06-10 2001-09-04 Abbott Laboratories Myostatin gene promoter and inhibition of activation thereof
FR2795093B1 (fr) 1999-06-21 2003-08-22 Inst Rech Developpement Ird Moyens pour l'identification du locus d'un gene majeur de la resistance au virus de la panachure jaune du riz et leurs applications
JP2003180356A (ja) 1999-07-09 2003-07-02 Mitsubishi Chemicals Corp アトピー遺伝子
AU6229800A (en) 1999-07-20 2001-02-05 Rockefeller University, The Conditional homologous recombination of large genomic vector inserts
US6475752B1 (en) 1999-07-30 2002-11-05 Incyte Genomics, Inc. Mammalian imidazoline receptor
US7074983B2 (en) 1999-11-19 2006-07-11 Kirin Beer Kabushiki Kaisha Transgenic bovine comprising human immunoglobulin loci and producing human immunoglobulin
AU1777301A (en) 1999-11-19 2001-05-30 Hematech, Llc Production of ungulates, preferably bovines that produce human immunoglobulins
US7414170B2 (en) * 1999-11-19 2008-08-19 Kirin Beer Kabushiki Kaisha Transgenic bovines capable of human antibody production
ES2170622B1 (es) 1999-12-03 2004-05-16 Consejo Superior De Investigaciones Cientificas Clones y vectores infectivos derivados de coronavirus y sus aplicaciones.
AUPQ462599A0 (en) 1999-12-13 2000-01-13 Polychip Pharmaceuticals Pty Ltd Yeast-based process for production of l-pac
CA2394600A1 (en) 1999-12-17 2001-06-21 Oregon Health And Science University Methods for producing transgenic animals
US6458561B1 (en) 2000-03-13 2002-10-01 Incyte Genomics, Inc. Human NIM1 kinase
US6492577B1 (en) 2000-03-16 2002-12-10 The Regents Of The University Of California Leafy cotyledon2 genes and their uses
JP2003530113A (ja) 2000-04-07 2003-10-14 フラームス・インテルウニフェルシタイル・インステイチュート・フォール・ビオテヒノロヒー・ヴェーゼットウェー 新規な染色体性ベクターおよびその用途
WO2002000842A2 (en) 2000-06-23 2002-01-03 The University Of Chicago Methods for isolating centromere dna
WO2002000916A2 (en) 2000-06-28 2002-01-03 California Institute Of Technology Methods for identifying an essential gene in a prokaryotic microorganism
US6548256B2 (en) 2000-07-14 2003-04-15 Eppendorf 5 Prime, Inc. DNA isolation method and kit
US6610006B1 (en) 2000-07-25 2003-08-26 C. R. Bard, Inc. Implantable prosthesis
US6730500B1 (en) 2000-08-30 2004-05-04 Zymogenetics, Inc. Methods for generating a continuous nucleotide sequence from noncontiguous nucleotide sequences
WO2002031202A2 (en) 2000-10-10 2002-04-18 Thomas Jefferson University High throughput genetic screening of lipid and cholesterol processing using fluorescent compounds
US6692954B1 (en) 2000-11-03 2004-02-17 The Scripps Research Institute Generation of human cytomegalovirus yeast artificial chromosome recombinants
WO2002070648A2 (en) * 2000-11-17 2002-09-12 Hematech, Llc Expression of xenogenous (human) immunoglobulins in cloned, transgenic ungulates
US6448041B1 (en) 2000-12-18 2002-09-10 Incyte Genomics, Inc. Colon cancer marker
AU2002226307A1 (en) 2001-01-25 2002-08-06 Evolva Biotech A/S Artificial chromosomes comprising concatemers of expressible nucleotide sequences
WO2002059296A2 (en) 2001-01-25 2002-08-01 Evolva Biotech A/S Concatemers of differentially expressed multiple genes
WO2002061073A2 (en) 2001-01-30 2002-08-08 Thomas Jefferson University Mutwnt fish for genetic screebibg of lipid and cholesterol metabolism
US20020108132A1 (en) 2001-02-02 2002-08-08 Avigenics Inc. Production of a monoclonal antibody by a transgenic chicken
US7323336B2 (en) 2001-02-21 2008-01-29 Verenium Corporation Enzymes having alpha amylase activity and methods of use thereof
WO2002070696A2 (en) 2001-03-07 2002-09-12 Andre Schuh Cd109 nucleic acid molecules polypeptides and methods of use
US6936469B2 (en) 2001-03-22 2005-08-30 Chromos Molecular Systems Inc. Methods for delivering nucleic acid molecules into cells and assessment thereof
NZ527972A (en) 2001-03-22 2006-04-28 Chromos Molecular Systems Inc Methods for delivering nucleic acid molecules into cells and assessment thereof
US20030186390A1 (en) 2001-03-22 2003-10-02 De Jong Gary Methods for delivering nucleic acid molecules into cells and assessment thereof
US6455026B1 (en) 2001-03-23 2002-09-24 Agy Therapeutics, Inc. Use of protein tyrosine phosphatase zeta as a biomolecular target in the treatment and visualization of brain tumors
AU2002303277A1 (en) 2001-04-06 2002-10-21 Vladimir Larionov Artificial chromosomes that can shuttle between bacteria, yeast, and mammalian cells
US6472177B1 (en) 2001-04-23 2002-10-29 Wisconsin Alumni Research Foundation Expression vector with dual control of replication and transcription
EP1385859A2 (en) 2001-05-10 2004-02-04 Baylor College Of Medicine Compositions and methods for array-based genomic nucleic acid analysis of biological molecules
DE60227067D1 (de) 2001-05-11 2008-07-24 Kirin Pharma Kk Künstliches menschliches chromosom mit dem gen für die lambda-leichte kette menschlicher antikörper
EP1401849A4 (en) 2001-05-30 2005-05-18 Chromos Molecular Systems Inc ARTIFICIAL PLANT CHROMOSOMES, THEIR USE AND METHOD FOR THE MANUFACTURE OF ARTIFICIAL PLANT CHROMOSOMES
IL157746A0 (en) 2001-05-30 2004-03-28 Chromos Molecular Systems Inc Chromosome-based platforms
CA2449591A1 (en) 2001-06-11 2002-12-19 Jurgen Peter Lode Del-Favero Brain expressed gene and protein associated with bipolar disorder
US6638722B2 (en) 2001-06-13 2003-10-28 Invitrogen Corporation Method for rapid amplification of DNA
WO2003006610A2 (en) 2001-07-09 2003-01-23 Diversa Corporation Thermostable phosphatases and methods of making and using them
EP1513860A2 (en) 2001-08-03 2005-03-16 Diversa Corporation P450 enzymes, nucleic acids encoding them and methods of making and using them
WO2003012126A2 (en) 2001-08-03 2003-02-13 Diversa Corporation Epoxide hydrolases, nucleic acids encoding them and methods for making and using them
AU2002331777A1 (en) 2001-08-30 2003-03-18 Spectral Genomics, Inc. Arrays comprising pre-labeled biological molecules and methods for making and using these arrays
CA2458303A1 (en) 2001-09-17 2003-03-27 Janssen Pharmaceutica N.V. Brain expressed cap-2 gene and protein associated with bipolar disorder
ATE533856T1 (de) 2001-09-27 2011-12-15 Perkinelmer Las Inc Verfahren zum nachweis genetischer mosaike mit arrays
AU2002367886B8 (en) 2001-10-12 2008-08-14 Perkinelmer Las, Inc. Compilations of nucleic acids and arrays and methods of using them
US7435871B2 (en) * 2001-11-30 2008-10-14 Amgen Fremont Inc. Transgenic animals bearing human Igλ light chain genes
US20030124542A1 (en) 2001-12-28 2003-07-03 Spectral Genomics, Inc. Methods for mapping the chromosomal loci of genes expressed by a cell
EP1465986A4 (en) * 2001-12-29 2005-01-26 Woo Suk Hwang GFP-TRANSFECTED CLONING PIG, GT-KNOCKOUT CLONING PIG, AND METHOD FOR THE MANUFACTURE THEREOF
US7482332B2 (en) 2002-01-04 2009-01-27 The Board Of Trustees Of The Leland Stanford Junior University Telomere-encoding synthetic DNA nanocircles, and their use for the elongation of telomere repeats
CN101287827A (zh) 2002-01-28 2008-10-15 戴弗萨公司 具有二级酰胺酶活性的酶及其应用方法
AU2003219994B2 (en) 2002-03-04 2009-04-09 The Texas A & M University System Quantitative trait loci and somatostatin
ATE471382T1 (de) 2002-04-10 2010-07-15 Us Gov Health & Human Serv Vac-bac-shuttlevektor-system
CA2495787A1 (en) 2002-05-01 2003-11-13 Chromos Molecular Systems, Inc. Methods for delivering nucleic acid molecules into cells and assessment thereof
ATE464389T1 (de) 2002-05-17 2010-04-15 Kyowa Hakko Kirin Co Ltd Transgene huftiere, die zur produktion von menschlichen antikörpern fähig sind
CA2487897A1 (en) 2002-05-31 2003-12-11 University Of Rochester Helper virus-free herpesvirus amplicon particles and uses thereof
WO2004007750A2 (en) 2002-07-11 2004-01-22 Diversa Corporation Monooxygenases, nucleic acids encoding them and methods for making and using them
WO2004009788A2 (en) 2002-07-19 2004-01-29 Diversa Corporation Fluorescent proteins, nucleic acids encoding them and methods for making and using them
US20060252156A1 (en) 2002-08-01 2006-11-09 Evolva Ltd. C/O Dr. Iur. Martin Eisenring Methods of mixing large numbers of heterologous genes
AU2003257155A1 (en) 2002-08-02 2004-02-23 The General Hospital Corporation Methods for the production of cells and mammals with desired genetic modifications
EP1534819B1 (en) 2002-08-21 2009-12-09 Revivicor, Inc. Porcine animals lacking any expression of functional alpha 1,3 galactosyltransferase
US7414119B2 (en) 2002-09-20 2008-08-19 Verenium Corporation Aldolases, nucleic acids encoding them and methods for making and using them
CN1717483A (zh) 2002-10-04 2006-01-04 麒麟麦酒株式会社 人类人工染色体(hac)载体
EP1578935A2 (en) 2002-10-10 2005-09-28 Diversa Corporation Proteases, nucleic acids encoding them and methods for making and using them
US20060281908A1 (en) 2002-11-06 2006-12-14 Walter Callen Xylose isomerases, nucleic acids encoding them and methods for making and using them
AU2003290689A1 (en) 2002-11-08 2004-06-03 Kyowa Hakko Kirin Co., Ltd. Transgenic ungulates having reduced prion protein activity and uses thereof
AU2002952993A0 (en) 2002-11-29 2002-12-12 The Corporation Of The Trustees Of The Order Of The Sisters Of Mercy In Queensland Therapeutic and diagnostic agents
WO2004066945A2 (en) 2003-01-24 2004-08-12 Diversa Corporation Enzymes and the nucleic acids encoding them and methods for making and using them
EP1639083A4 (en) * 2003-06-06 2008-05-28 Univ Pittsburgh GENE OF CMP-N-ACETYLNEURAMIC ACID HYDROXYLASE FROM PIG
AU2004290006A1 (en) * 2003-11-05 2005-05-26 University Of Pittsburgh Porcine isogloboside 3 synthase protein, cDNA, genomic organization, and regulatory region
AU2005243169A1 (en) * 2004-05-07 2005-11-24 University Of Pittsburgh Of The Commonwealth System Of Higher Education Porcine Forssman synthetase protein, cDNA, genomic organization, and regulatory region
DK2348827T3 (en) * 2008-10-27 2015-07-20 Revivicor Inc IMMUNICIPLY COMPROMATED PETS

Also Published As

Publication number Publication date
KR20070072608A (ko) 2007-07-04
JP7308243B2 (ja) 2023-07-13
JP2015154786A (ja) 2015-08-27
WO2006047603A3 (en) 2007-05-18
US20060130157A1 (en) 2006-06-15
EP1811832A4 (en) 2009-12-30
JP2021192647A (ja) 2021-12-23
NZ554824A (en) 2010-10-29
CN101389214A (zh) 2009-03-18
CA2585098A1 (en) 2006-05-04
JP2008517608A (ja) 2008-05-29
CA2958259C (en) 2020-06-30
JP2012196234A (ja) 2012-10-18
EP1811832A2 (en) 2007-08-01
CA2958259A1 (en) 2006-05-04
CA3079874A1 (en) 2006-05-04
WO2006047603A2 (en) 2006-05-04
CA2585098C (en) 2018-12-18
CA3079874C (en) 2023-01-03
JP2018086031A (ja) 2018-06-07
EP2527456B1 (en) 2018-05-16
JP7058522B2 (ja) 2022-04-22
EP2527456A1 (en) 2012-11-28
AU2005299413A1 (en) 2006-05-04

Similar Documents

Publication Publication Date Title
ES2679282T3 (es) Porcinos transgénicos que carecen de cadena ligera de inmunoglobulina endógena
JP6770568B2 (ja) 限定された免疫グロブリン重鎖のマウス
TWI827567B (zh) 具有經改造免疫球蛋白λ輕鏈的非人類動物及其用途
ES2759617T3 (es) Animales no humanos humanizados con loci restringidos de cadena pesada de inmunoglobulina
ES2963516T3 (es) Polinucleótidos que codifican anticuerpos de roedores con idiotipos humanos y animales que los contienen
ES2664218T3 (es) Composiciones y procedimientos de inhibición de genes de inmunoglobulinas endógenas y de producción de anticuerpos idiotípicos humanos transgénicos
CN104994730B (zh) 具有修饰的免疫球蛋白重链序列的非人类动物
RU2757665C2 (ru) Отличные от человека животные со сконструированным локусом легкой лямбда-цепи иммуноглобулина
ES2250105T3 (es) Anticuerpos policlonales humanos de animales transgenicos no humanos.
JP2022512638A (ja) 動物モデル及び治療用分子
US20230340524A1 (en) Transgenic mouse models supporting human innate immune function
Mendicino et al. Generation of antibody-and B cell-deficient pigs by targeted disruption of the J-region gene segment of the heavy chain locus
JP2008517608A5 (enExample)
TW202110323A (zh) 具有表現自κ 基因座的有限λ 輕鏈組庫的非人類動物及其用途
CN101595128A (zh) 免疫应答增强的转基因动物和用于制备其的方法
KR102617284B1 (ko) 면역글로불린 중쇄 암호화 서열에서 dh-dh 재배열 가능한 비인간 동물
CN110662421A (zh) 来自具有多个重链免疫球蛋白基因座的转基因啮齿类动物的人抗体
ES2548377T3 (es) Ungulados inmunodeprimidos
JP7776486B2 (ja) ヒトｈｌａ－ａ２０１制限遺伝子を発現するトランスジェニックマウスモデル
Ishida et al. Production of a diverse repertoire of human antibodies in genetically engineered mice
Robl Application of cloning technology for production of human polyclonal antibodies in cattle
RU2801802C2 (ru) Животные, отличные от человека, способные к dh-dh-перегруппировке сконструированных генных сегментов, и пути их применения
JP2005192468A (ja) Ｅ３ユビキチンリガーゼ遺伝子導入トランスジェニック動物
NZ749259B2 (en) Polynucleotides encoding rodent antibodies with human idiotypes and animals comprising same